This study was sponsored by the National Natural Science Foundation of China (No. 81472377) and the Natural Science Foundation of Shanghai (No. 16ZR1406500). The authors also thank Wei-Yi Yang, Cui-Zhu Zhang, and Ying Shen for helping with follow-up of patients.
This study aimed to assess the role of the National Comprehensive Cancer Network (NCCN) risk classification in predicting biochemical recurrence (BCR) after radical prostatectomy (RP) in Chinese prostate cancer ...
In this paper, we apply the method of directly defining the inverse mapping introduced by Liao and Zhao [On the method of directly defining inverse mapping for nonlinear differential equations, Numer. Algorithms 72(4...
The last decade has seen remarkable advances in the treatment of prostatecancer. Until 2010, only docetaxel had demonstrated the ability to improve the survival in metastatic castration-resistant prostate cancer (mC...
Bone metastases are the main driver of morbidity and mortality in advanced prostate cancer. Targeting the bone microenvironment, a key player in the pathogenesis of bone metastasis, has become one of the mainstays of ...
Chemotherapy in prostate cancer (PCa) has undergone dramatic landscape changes. While earlier studies utilized varying chemotherapy regimens which were found to be largely palliative in nature and hardly resulted in...
Signaling through the vitamin D receptor has been shown to be biologically active and important in a number of preclinical studies in prostate and other cancers. Epidemiologic data also indicate that vitamin D signali...
This work was supported by the National Natural Science Foundation of China (No 81272687 and 81573000), Zhejiang Provincial Natural Science Foundation of China (No LY16H160056), Zhejiang Province Health Department (No 2014RCA022), Grant for 521 Talent Project of ZSTU and Aca- demician Workstation of Zhejiang Province.
GOLPH2 (also called GP73) is a Golgi glycoprotein, which has been identified as a novel tumor marker upregulated in various cancers, including prostate cancer (PCa). GD55 is a novel GOLPH2-regulated oncolytic aden...
Although adenocarcinomas of the prostate are relatively indolent, some patients with advanced adenocarcinomas show recurrence of treatment-induced neuroendocrine prostate cancer, which is highly aggressive and lethal....
The aim of this study is to identify optimal patients for adjuvant radiation therapy (ART) in pT3 prostate cancer. The role of ART for patients with adverse pathologic features after radical prostatectomy (RP) has...
The aim of this study is to evaluate the ability of the random forest algorithm that combines data on transrectal ultrasound findings, age, and serum levels of prostate-specific antigen to predict prostate carcinoma. ...